Application

18924707 · VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

Filed 2024-10-23 · Granted · Patent 12331099 (2025-06-17) The official file ↗The patent and its PDF ↗ · Art unit 1647 · Examiner Jon McClelland Lockard Easy · CPC C07K 14/71 · Regeneron Pharmaceuticals, Inc. · A&P - Regeneron (Prosecution)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

1.0 mo

to disposition 7.8 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.